Clinical Trials in North Carolina

Showing 7121-7140 of 15,496 trials

Well-Child Visit Trial

NCT05086237

This project will use Twilio as a platform for a text messaging campaign to implement timely follow up with parents/guardians of children ages 0 to 17 years who have missed Well Child Visits (WCVs). The first phase of this project was an open trial. This second phase of the study will be a randomized controlled trial (RCT) to randomly assign parents/guardians of children who missed a WCV to an intervention condition or no intervention, and assess reasons for missed visits and experiences at last visit. Parents/guardians will receive text messages notifying them of missed visits and prompting them to reschedule, as well as inviting them to complete an online survey. Each reminder message will at minimum direct parents/guardians to reschedule by phone or by the patient portal. Outcomes of the follow-up campaign will be evaluated, including rescheduled visits within 6 weeks of missed visit and attendance at rescheduled visit. This aim will incorporate patient Electronic Health Record (EHR) data into mixed effects logistic regressions for the primary study outcomes.

Child HealthText Messaging

Wake Forest University Health Sciences739 participantsStarted May 2022

Winston-Salem, North Carolina, United States

COMPLETEDPhase 341 miles

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

NCT01335399

The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS)

Multiple Myeloma

Bristol-Myers Squibb748 participantsStarted Aug 2011

Birmingham, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +232 more locations

Well-Child Visit Trial

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

Find Trials by Condition in North Carolina

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Dysport® Adult Upper Limb Spasticity Extension Study

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Circulating Tumor Cells in Solid Tumors

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

Natural History of Optic Neuritis

Chronic Total Occlusion Percutaneous Coronary Intervention Study

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

StatStrip Glucose/Ketone Meter System Ketone Evaluation

Long-Term Retention of Gadolinium in Bone